REPORT ID 6976

EMEA (Europe, Middle East and Africa) Ubiquitin Enzymes Market Report 2017

Publish Date
1-Nov-17
Pages
120
Format
Electronic (PDF)

In this report, the EMEA Ubiquitin Enzymes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Ubiquitin Enzymes for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ubiquitin Enzymes market competition by top manufacturers/players, with Ubiquitin Enzymes sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    3SBio
    5AM Ventures
    Abbiotec
    Abcam
    AcelRx Pharmaceuticals
    Aegera Therapeutics
    Aeneas Ventures
    Agilis Biotherapeutics
    Aileron Therapeutics
    Aju IB Investment
    Alexion Pharmaceuticals
    Almac Discovery
    Amgen
    Angelman Syndrome Foundation
    Apeiron Biologics
    Boston Biochem
    Boston University Technology Development Fund
    BostonBiochem
    BPS Biosciences
    Business Development Bank of Canada
    Business Development Corporation (BDC) Capital
    C4 Therapeutics
    Calculus Capital
    Canaan Partners
    Cancer Research Technology
    Captor Therapeutics
    Carmot Therapeutics
    Cayman Chemicals
    Celgene Corporation
    Cell Signaling Technology

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
    E3 ENZYMES AS THERAPEUTIC TARGETS
    DUB ENZYMES AS THERAPEUTIC TARGETS
    ASSOCIATED DRUG CLASSES

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Ubiquitin Enzymes for each application, including
    Cancer
    Biological Engineering
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Ubiquitin Enzymes Market Report 2017
1 Ubiquitin Enzymes Overview
    1.1 Product Overview and Scope of Ubiquitin Enzymes
    1.2 Classification of Ubiquitin Enzymes
        1.2.1 EMEA Ubiquitin Enzymes Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Ubiquitin Enzymes Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 E1 AND E2 ENZYMES AS THERAPEUTIC TARGETS
        1.2.4 E3 ENZYMES AS THERAPEUTIC TARGETS
        1.2.5 DUB ENZYMES AS THERAPEUTIC TARGETS
        1.2.6 ASSOCIATED DRUG CLASSES
    1.3 EMEA Ubiquitin Enzymes Market by Application/End Users
        1.3.1 EMEA Ubiquitin Enzymes Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Cancer
        1.3.3 Biological Engineering
        1.3.4 Others
    1.4 EMEA Ubiquitin Enzymes Market by Region
        1.4.1 EMEA Ubiquitin Enzymes Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Ubiquitin Enzymes (2012-2022)
        1.5.1 EMEA Ubiquitin Enzymes Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Ubiquitin Enzymes Revenue and Growth Rate (2012-2022)

2 EMEA Ubiquitin Enzymes Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Ubiquitin Enzymes Market Competition by Players/Manufacturers
        2.1.1 EMEA Ubiquitin Enzymes Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Ubiquitin Enzymes Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Ubiquitin Enzymes Sale Price by Players (2012-2017)
    2.2 EMEA Ubiquitin Enzymes (Volume and Value) by Type/Product Category
        2.2.1 EMEA Ubiquitin Enzymes Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Ubiquitin Enzymes Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Ubiquitin Enzymes Sale Price by Type (2012-2017)
    2.3 EMEA Ubiquitin Enzymes (Volume) by Application
    2.4 EMEA Ubiquitin Enzymes (Volume and Value) by Region
        2.4.1 EMEA Ubiquitin Enzymes Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Ubiquitin Enzymes Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Ubiquitin Enzymes Sales Price by Region (2012-2017)

3 Europe Ubiquitin Enzymes (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Ubiquitin Enzymes Sales and Value (2012-2017)
        3.1.1 Europe Ubiquitin Enzymes Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Ubiquitin Enzymes Revenue and Growth Rate (2012-2017)
    3.2 Europe Ubiquitin Enzymes Sales and Market Share by Type
    3.3 Europe Ubiquitin Enzymes Sales and Market Share by Application
    3.4 Europe Ubiquitin Enzymes Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Ubiquitin Enzymes Sales Volume by Countries (2012-2017)
        3.4.2 Europe Ubiquitin Enzymes Revenue by Countries (2012-2017)
        3.4.3 Germany Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        3.4.4 France Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        3.4.5 UK Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        3.4.6 Russia Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        3.4.7 Italy Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Ubiquitin Enzymes Sales and Growth Rate (2012-2017)

4 Middle East Ubiquitin Enzymes (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Ubiquitin Enzymes Sales and Value (2012-2017)
        4.1.1 Middle East Ubiquitin Enzymes Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Ubiquitin Enzymes Revenue and Growth Rate (2012-2017)
    4.2 Middle East Ubiquitin Enzymes Sales and Market Share by Type
    4.3 Middle East Ubiquitin Enzymes Sales and Market Share by Application
    4.4 Middle East Ubiquitin Enzymes Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Ubiquitin Enzymes Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Ubiquitin Enzymes Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        4.4.4 Israel Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        4.4.5 UAE Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        4.4.6 Iran Ubiquitin Enzymes Sales and Growth Rate (2012-2017)

5 Africa Ubiquitin Enzymes (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Ubiquitin Enzymes Sales and Value (2012-2017)
        5.1.1 Africa Ubiquitin Enzymes Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Ubiquitin Enzymes Revenue and Growth Rate (2012-2017)
    5.2 Africa Ubiquitin Enzymes Sales and Market Share by Type
    5.3 Africa Ubiquitin Enzymes Sales and Market Share by Application
    5.4 Africa Ubiquitin Enzymes Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Ubiquitin Enzymes Sales Volume by Countries (2012-2017)
        5.4.2 Africa Ubiquitin Enzymes Revenue by Countries (2012-2017)
        5.4.3 South Africa Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Ubiquitin Enzymes Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Ubiquitin Enzymes Sales and Growth Rate (2012-2017)

6 EMEA Ubiquitin Enzymes Manufacturers/Players Profiles and Sales Data
    6.1 3SBio
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 3SBio Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 5AM Ventures
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 5AM Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abbiotec
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbiotec Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abcam
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abcam Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AcelRx Pharmaceuticals
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AcelRx Pharmaceuticals Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Aegera Therapeutics
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Aegera Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Aeneas Ventures
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Aeneas Ventures Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Agilis Biotherapeutics
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Agilis Biotherapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Aileron Therapeutics
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Aileron Therapeutics Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Aju IB Investment
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Ubiquitin Enzymes Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Aju IB Investment Ubiquitin Enzymes Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Alexion Pharmaceuticals
    6.12 Almac Discovery
    6.13 Amgen
    6.14 Angelman Syndrome Foundation
    6.15 Apeiron Biologics
    6.16 Boston Biochem
    6.17 Boston University Technology Development Fund
    6.18 BostonBiochem
    6.19 BPS Biosciences
    6.20 Business Development Bank of Canada
    6.21 Business Development Corporation (BDC) Capital
    6.22 C4 Therapeutics
    6.23 Calculus Capital
    6.24 Canaan Partners
    6.25 Cancer Research Technology
    6.26 Captor Therapeutics
    6.27 Carmot Therapeutics
    6.28 Cayman Chemicals
    6.29 Celgene Corporation
    6.30 Cell Signaling Technology

7 Ubiquitin Enzymes Manufacturing Cost Analysis
    7.1 Ubiquitin Enzymes Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ubiquitin Enzymes

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ubiquitin Enzymes Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ubiquitin Enzymes Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Ubiquitin Enzymes Market Forecast (2017-2022)
    11.1 EMEA Ubiquitin Enzymes Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Ubiquitin Enzymes Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Ubiquitin Enzymes Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Ubiquitin Enzymes Price and Trend Forecast (2017-2022)
    11.2 EMEA Ubiquitin Enzymes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Ubiquitin Enzymes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Ubiquitin Enzymes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Ubiquitin Enzymes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Ubiquitin Enzymes Sales Forecast by Type (2017-2022)
    11.7 EMEA Ubiquitin Enzymes Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer